GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (TSE:4506) » Definitions » Shiller PE Ratio

Sumitomo Pharma Co (TSE:4506) Shiller PE Ratio : 9.37 (As of May. 03, 2024)


View and export this data going back to 1949. Start your Free Trial

What is Sumitomo Pharma Co Shiller PE Ratio?

As of today (2024-05-03), Sumitomo Pharma Co's current share price is 円373.00. Sumitomo Pharma Co's E10 for the quarter that ended in Dec. 2023 was 円39.80. Sumitomo Pharma Co's Shiller PE Ratio for today is 9.37.

The historical rank and industry rank for Sumitomo Pharma Co's Shiller PE Ratio or its related term are showing as below:

TSE:4506' s Shiller PE Ratio Range Over the Past 10 Years
Min: 7.49   Med: 21.57   Max: 61.38
Current: 10.05

During the past years, Sumitomo Pharma Co's highest Shiller PE Ratio was 61.38. The lowest was 7.49. And the median was 21.57.

TSE:4506's Shiller PE Ratio is ranked better than
87.62% of 533 companies
in the Drug Manufacturers industry
Industry Median: 24.95 vs TSE:4506: 10.05

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sumitomo Pharma Co's adjusted earnings per share data for the three months ended in Dec. 2023 was 円-125.770. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円39.80 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sumitomo Pharma Co Shiller PE Ratio Historical Data

The historical data trend for Sumitomo Pharma Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Shiller PE Ratio Chart

Sumitomo Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.78 20.31 24.43 13.16 11.05

Sumitomo Pharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.71 11.05 10.18 9.74 11.71

Competitive Comparison of Sumitomo Pharma Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Shiller PE Ratio falls into.



Sumitomo Pharma Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sumitomo Pharma Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=373.00/39.8
=9.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Sumitomo Pharma Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-125.77/106.8000*106.8000
=-125.770

Current CPI (Dec. 2023) = 106.8000.

Sumitomo Pharma Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 2.270 95.700 2.533
201406 14.490 98.000 15.791
201409 15.110 98.500 16.383
201412 18.210 97.900 19.865
201503 -8.930 97.900 -9.742
201506 14.950 98.400 16.226
201509 18.306 98.500 19.849
201512 25.499 98.100 27.760
201603 3.400 97.900 3.709
201606 21.060 98.100 22.928
201609 6.430 98.000 7.007
201612 46.939 98.400 50.946
201703 4.390 98.100 4.779
201706 61.970 98.500 67.192
201709 52.130 98.800 56.351
201712 -3.630 99.400 -3.900
201803 24.050 99.200 25.893
201806 38.380 99.200 41.320
201809 31.770 99.900 33.964
201812 30.460 99.700 32.629
201903 21.790 99.700 23.342
201906 16.870 99.800 18.053
201909 59.470 100.100 63.451
201912 34.350 100.500 36.503
202003 -8.120 100.300 -8.646
202006 45.960 99.900 49.134
202009 47.920 99.900 51.230
202012 82.960 99.300 89.226
202103 -35.340 99.900 -37.781
202106 12.090 99.500 12.977
202109 79.660 100.100 84.992
202112 24.940 100.100 26.609
202203 25.300 101.100 26.726
202206 78.300 101.800 82.146
202209 -96.630 103.100 -100.098
202212 -28.240 104.100 -28.972
202303 -140.980 104.400 -144.221
202306 -97.820 105.200 -99.308
202309 -72.680 106.200 -73.091
202312 -125.770 106.800 -125.770

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sumitomo Pharma Co  (TSE:4506) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Sumitomo Pharma Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sumitomo Pharma Co (TSE:4506) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Sumitomo Pharma Co (TSE:4506) Headlines

No Headlines